Vital KSK Holdings, Inc. (TYO:3151)

Japan · Delayed Price · Currency is JPY

1,520.00

-13.00 (-0.85%)

Jun 26, 2026, 3:30 PM JST

28.38% (1Y)

Market Cap	73.53B +20.6%
Revenue (ttm)	610.50B +1.7%
Net Income	7.36B +0.7%
EPS	152.28 +2.2%
Shares Out	48.38M
PE Ratio	9.98
Forward PE	n/a
Dividend	70.00 (4.57%)
Ex-Dividend Date	Mar 30, 2026

Volume	58,200
Open	1,530.00
Previous Close	1,533.00
Day's Range	1,512.00 - 1,548.00
52-Week Range	1,180.00 - 1,649.00
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Vital KSK Holdings

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2009

Employees 3,756

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 3151

Full Company Profile

Financial Performance

In fiscal year 2026, Vital KSK Holdings's revenue was 610.50 billion, an increase of 1.69% compared to the previous year's 600.37 billion. Earnings were 7.36 billion, an increase of 0.74%.

Financial Statements